Literature DB >> 21696830

Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.

Christian J Teter1, Anthony E Falone, Amanda M Bakaian, Chunhao Tu, Dost Ongür, Roger D Weiss.   

Abstract

We examined the impact of substance use disorder (SUD) history among patients with bipolar I disorder (BD) in regards to medication-taking behaviors and attitudes. Interviews were conducted with inpatients hospitalized for BD, which included diagnostic instruments and measures of attitudes concerning psychiatric medications. We compared patients with BD and no history of SUD (BD-NH), BD and past history of SUD (BD-PH), and BD and current SUD (BD-C). The primary outcome variable was a standardized medication adherence ratio (SMAR) of [medication taken]/[medication prescribed]. Fifty-four patients with a BD diagnosis participated, which included BD-NH (n=26), BD-PH (n=19), and BD-C (n=9). The SMAR was significantly different among the three groups; post-hoc analyses revealed the SMAR was significantly lower among BD-C (M=0.70) compared to BD-NH (M=0.90) and BD-PH (M=0.97) patients. This finding remained significant after controlling for numerous patient characteristics. Attitudes regarding medications, measured by the Drug Attitude Inventory (DAI), were positive among a significantly higher percentage of BD-PH (89.47%) and BD-NH (65.38%) compared to BD-C (44.44%) patients. In conclusion, patients with BD-C demonstrated poor medication adherence and attitudes concerning medication management. Helping patients with BD achieve remission from SUD may lead to a more successful course of BD pharmacotherapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21696830      PMCID: PMC3663075          DOI: 10.1016/j.psychres.2011.05.042

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  26 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

2.  Compliance with maintenance treatment in bipolar disorder.

Authors:  P E Keck; S L McElroy; S M Strakowski; M L Bourne; S A West
Journal:  Psychopharmacol Bull       Date:  1997

3.  Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.

Authors:  Roy H Perlis; Michael J Ostacher; David J Miklowitz; Aleena Hay; Andrew A Nierenberg; Michael E Thase; Gary S Sachs
Journal:  J Clin Psychiatry       Date:  2010-03       Impact factor: 4.384

4.  Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

Authors:  R C Kessler; R M Crum; L A Warner; C B Nelson; J Schulenberg; J C Anthony
Journal:  Arch Gen Psychiatry       Date:  1997-04

5.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

6.  A history of substance abuse complicates remission from acute mania in bipolar disorder.

Authors:  J F Goldberg; J L Garno; A C Leon; J H Kocsis; L Portera
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

7.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

Review 8.  Adherence to pharmacotherapy in patients with alcohol and opioid dependence.

Authors:  Roger D Weiss
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

9.  Factors associated with pharmacologic noncompliance in patients with mania.

Authors:  P E Keck; S L McElroy; S M Strakowski; S P Stanton; D L Kizer; T M Balistreri; J A Bennett; K C Tugrul; S A West
Journal:  J Clin Psychiatry       Date:  1996-07       Impact factor: 4.384

10.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

View more
  9 in total

1.  Predictors of first-onset substance use disorders during the prospective course of bipolar spectrum disorders in adolescents.

Authors:  Benjamin I Goldstein; Michael Strober; David Axelson; Tina R Goldstein; Mary Kay Gill; Heather Hower; Daniel Dickstein; Jeffrey Hunt; Shirley Yen; Eunice Kim; Wonho Ha; Fangzi Liao; Jieyu Fan; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07-31       Impact factor: 8.829

2.  Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement.

Authors:  Abigail J Herron; John J Mariani; Martina Pavlicova; Christina M Parrinello; Krysten W Bold; Frances R Levin; Edward V Nunes; Maria A Sullivan; Wilfred N Raby; Adam Bisaga
Journal:  Drug Alcohol Depend       Date:  2012-08-22       Impact factor: 4.492

3.  Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder.

Authors:  Ching-Wen Chang; Martha Sajatovic; Curtis Tatsuoka
Journal:  Bipolar Disord       Date:  2014-06-26       Impact factor: 6.744

Review 4.  A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Authors:  David R Gastfriend
Journal:  Ann N Y Acad Sci       Date:  2014-09-18       Impact factor: 5.691

Review 5.  Treatment-adherence in bipolar disorder: A patient-centred approach.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2016-12-22

Review 6.  Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review.

Authors:  Martha Sajatovic; Faith DiBiasi; Susan N Legacy
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-30       Impact factor: 2.570

7.  A Cross-sectional Analysis of Patterns and Predictors of Medication Adherence in Bipolar Disorder: Single Center Experience from South India.

Authors:  Nivedhitha Selvakumar; Vikas Menon; Shivan Kattimani
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

8.  Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi.

Authors:  Japhet Myaba; Charles M Mwale; Vincent C Jumbe
Journal:  Malawi Med J       Date:  2021-04       Impact factor: 1.413

9.  Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning.

Authors:  Jose Manuel Montes; Jorge Maurino; Consuelo de Dios; Esteban Medina
Journal:  Patient Prefer Adherence       Date:  2013-01-18       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.